Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Topical delivery enhancement of ketoconazole by utilizing novasomal vesicular systems

Duaa Jabar Sibti1, Muqdad Alhijjaj1,2 , Dawood Chaloob Al_Bahadily3

1Department of Pharmaceutics, College of Pharmacy, University of Basrah, Basrah 61004,; 2Department of Pharmaceutics, College of Pharmacy, Al-Kunooze University, Basrah 61026,; 3Department of Clinical Laboratory Sciences, College of Pharmacy, University of Basrah, Basrah 61004, Iraq.

For correspondence:-  Muqdad Alhijjaj   Email: muqdad.mousa@uobasrah.edu.iq

Received: 23 May 2026        Accepted: 19 August 2026        Published: 31 August 2026

Citation: Sibti DJ, Alhijjaj M, Al_Bahadily DC. Topical delivery enhancement of ketoconazole by utilizing novasomal vesicular systems. Trop J Pharm Res 2026; 25(8):1039-1049 doi: https://dx.doi.org/10.4314/tjpr.v25i8.1

© 2026 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To determine the antifungal activity of ketoconazole-loaded novasomal delivery systems. Method: Ethanol injection method was used to fabricate ketoconazole-loaded novasomes using stearic acid (SA) and oleic acid (OA) as free fatty acids (FFA), with the surfactant (SAA) being Span 60, Brij 35, or a combination. Also, cholesterol (CHO) was added as a membrane stabilizer. Results: Cumulative drug release at 8 h for F9 was 87.33 ± 8.67 %, compared with 18.6 ± 4.96 % for pure ketoconazole suspension. Korsmeyer-Peppas model best fit the data (R2 = 0.987), and the n exponent was 0.615, suggesting non-Fickian diffusion (diffusion with membrane bilayer relaxation). Furthermore, F9 showed a high inhibition zone diameter (25 ± 2.6 mm and 23 ± 2.5 mm) on Candida albicans and Aspergillus niger, respectively, at 800 µg/mL compared to blank novasomes and pure ketoconazole suspension. The stability study demonstrated that F9 was best stored at 2 - 8 °C. Conclusion: The novasomes showed narrow PDI, potentiating the activity of ketoconazole by improving drug release and diffusion, and enhancing permeation through the fungal cell wall.

Keywords: Antifungal study, Ethanol injection method, Ketoconazole, Novasomes

Impact Factor
Thompson Reuters (ISI): 0.6 (2023)
H-5 index (Google Scholar): 49 (2023)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal: